The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized T cell therapy for metastatic colon cancer.
 
Sruthi Ravindranathan
Stock and Other Ownership Interests - Sellas Life Sciences (I)
Patents, Royalties, Other Intellectual Property - Emory University
 
Mohammad Raheel Jajja
No Relationships to Disclose
 
Alexandra Waller
No Relationships to Disclose
 
Ramireddy Bommireddy
No Relationships to Disclose
 
Christopher Petersen
Patents, Royalties, Other Intellectual Property - Emory University (Inst)
 
Periasamy Selvaraj
Leadership - Metaclipse Therapeutics
Stock and Other Ownership Interests - Metaclipse Therapeutics
Consulting or Advisory Role - Metaclipse Therapeutics
Research Funding - Metaclipse Therapeutics
Patents, Royalties, Other Intellectual Property - Metaclipse Therapeutics
Other Relationship - Metaclipse Therapeutics
 
Lily Yang
No Relationships to Disclose
 
Gregory B. Lesinski
Consulting or Advisory Role - ProDa
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Merck (Inst); Vaccinex
 
Bassel F. El-Rayes
Honoraria - Bayer; Lexicon; RTI Health Solutions
Consulting or Advisory Role - Bayer; BTG; Loxo; Merrimack; RTI Health Solutions
Speakers' Bureau - Bristol-Myers Squibb; Lexicon
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)
 
Brianna Flynn
Employment - IsoPlexis
Stock and Other Ownership Interests - IsoPlexis
 
Edmund K. Waller
Leadership - Cambium Medical Technologies
Stock and Other Ownership Interests - Cambium Medical Technologies; Cambium Medical Technologies; Cerus; Chimerix
Honoraria - Amgen; Celldex; Novartis; Partners Healthcare
Consulting or Advisory Role - Amgen; Kalytera Therapeutics; Novartis; Partners Healthcare
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Cambium Medical Technologies
Travel, Accommodations, Expenses - Pharmacyclics